Treatment compliance with first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study

Statistics

Original article

Cumplimiento terapéutico con terapias modificadoras de la enfermedad de primera línea en pacientes con esclerosis múltiple. Estudio COMPLIANCE

A. Saiza,

Corresponding author

asaiz@clinic.ub.es

Corresponding author.

, S. Morab, J. Blancob, en representación de los investigadores del estudio COMPLIANCE ◊

a Servicio de Neurología, Hospital Clínic i provincial de Barcelona, Universitat de Barcelona e Institut d¿Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain

b Departamento Médico, Novartis Farmacéutica S.A., Barcelona, Spain

Read

7136

Times
was read the article

1542

Total PDF

5594

Total HTML

Share statistics

Article information

ISSN: 21735808
Original language: English

DOI:10.1016/j.nrleng.2015.03.003

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 12	52	1	53
2025 11	173	51	224
2025 10	81	19	100
2025 9	88	16	104
2025 8	86	26	112
2025 7	116	8	124
2025 6	84	7	91
2025 5	80	9	89
2025 4	58	3	61
2025 3	83	3	86
2025 2	66	2	68
2025 1	61	4	65
2024 12	57	4	61
2024 11	30	6	36
2024 10	25	9	34
2024 9	65	6	71
2024 8	42	4	46
2024 7	15	7	22
2024 6	31	4	35
2024 5	36	5	41
2024 4	42	16	58
2024 3	35	6	41
2024 2	50	12	62
2024 1	44	13	57
2023 12	40	11	51
2023 11	54	9	63
2023 10	64	9	73
2023 9	48	4	52
2023 8	43	10	53
2023 7	36	8	44
2023 6	81	7	88
2023 5	55	12	67
2023 4	45	8	53
2023 3	57	1	58
2023 2	45	5	50
2023 1	70	8	78
2022 12	44	10	54
2022 11	64	17	81
2022 10	46	16	62
2022 9	39	17	56
2022 8	46	12	58
2022 7	38	14	52
2022 6	49	12	61
2022 5	54	21	75
2022 4	69	10	79
2022 3	53	9	62
2022 2	36	6	42
2022 1	31	12	43
2021 12	26	13	39
2021 11	36	7	43
2021 10	42	19	61
2021 9	40	9	49
2021 8	49	10	59
2021 7	35	21	56
2021 6	31	22	53
2021 5	39	10	49
2021 4	89	24	113
2021 3	43	7	50
2021 2	32	8	40
2021 1	26	8	34
2020 12	21	10	31
2020 11	22	9	31
2020 10	31	6	37
2020 9	35	15	50
2020 8	49	12	61
2020 7	36	10	46
2020 6	25	11	36
2020 5	34	21	55
2020 4	27	11	38
2020 3	37	8	45
2020 2	88	5	93
2020 1	37	13	50
2019 12	48	5	53
2019 11	22	15	37
2019 10	35	6	41
2019 9	133	11	144
2019 8	19	4	23
2019 7	36	22	58
2019 6	77	32	109
2019 5	157	31	188
2019 4	83	29	112
2019 3	27	13	40
2019 2	19	9	28
2019 1	21	18	39
2018 12	23	1	24
2018 11	27	12	39
2018 10	33	18	51
2018 9	42	7	49
2018 8	22	7	29
2018 7	10	1	11
2018 6	9	2	11
2018 5	13	6	19
2018 4	3	7	10
2018 3	10	1	11
2018 2	3	1	4
2018 1	6	6	12
2017 12	10	4	14
2017 11	13	5	18
2017 10	16	2	18
2017 9	10	15	25
2017 8	16	2	18
2017 7	12	2	14
2017 6	51	7	58
2017 5	20	6	26
2017 4	14	3	17
2017 3	20	38	58
2017 2	22	10	32
2017 1	42	9	51
2016 12	38	13	51
2016 11	24	10	34
2016 10	41	6	47
2016 9	40	23	63
2016 8	53	10	63
2016 7	34	6	40
2016 6	53	15	68
2016 5	29	28	57
2016 4	38	27	65
2016 3	50	24	74
2016 2	62	21	83
2016 1	28	22	50
2015 12	31	21	52
2015 11	26	14	40
2015 10	28	16	44
2015 9	35	22	57
2015 8	58	14	72
2015 7	40	16	56
2015 6	35	33	68
2015 5	71	46	117
2015 4	19	10	29

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter